Unibest 优贝德
← Back to patent-cliff list

吡昔替尼

Tier C — Watch / trade

Pexidartinib

第一三共株式会社
Originator
2019
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type

TargetsKIT、CSF1R、FLT3

BrandTuralio

Indications (approved)腱鞘巨细胞瘤

Regional status

US
批准上市
2019-08-02
EU
终止
China
临床三期
2020-09-25
Japan
临床二期
2021-03-15

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 6 · Total yield 13.50 mg
Synthetic routes & intermediates Route 1
CodeCAS No.Intermediate
PEXI-001866546-07-85-chloro-1H-pyrrolo[2,3-b]pyridine
PEXI-002954112-61-95-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde
PEXI-0031029052-72-95-chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde
PEXI-0041072-97-55-bromopyridin-2-amine
PEXI-0051029052-73-0(6-aminopyridin-3-yl)(5-chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)methanol
PEXI-0061029052-74-15-((5-chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl)pyridin-2-amine
PEXI-007386704-12-76-(trifluoromethyl)nicotinaldehyde
PEXI-008-5-((5-chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl)-N-((6-(trifluoromethyl)pyridin-3-yl)methyl)pyridin-2-amine

Frequently asked questions

What are the approved indications of Pexidartinib?

Approved indications include: 腱鞘巨细胞瘤.

When does the Pexidartinib patent expire?

No public expiry year is available for Pexidartinib yet; this page updates once verified.

How many synthesis routes are recorded for Pexidartinib?

1 synthesis routes are recorded; the shortest is 6 steps with 13.50 mg total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Pexidartinib intermediates?

All intermediates in Pexidartinib routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Pexidartinib intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-24